Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Formalin is an aqueous solution of formaldehyde, typically containing about 37% (by weight) of formaldehyde gas dissolved in water and stabilized with 10–15% methanol to prevent polymerization[1][9]. It is a clear, colorless liquid with a strong pungent odor. Formalin acts as a potent fixative and preservative due to its ability to cross-link proteins and nucleic acids. Its primary mechanism of action is the denaturation and cross-linking of biological macromolecules, which preserves tissue structure for histological examination or long-term storage[1][6]. In medicine, it is widely used for tissue fixation in pathology labs, preservation of biological specimens (anatomy/museum samples), sterilization/disinfection (including medical equipment), vaccine production (virus/bacterial toxin inactivation), and occasionally as a topical agent for refractory hemorrhagic proctitis[6][8][10]. Formalin’s antimicrobial properties make it effective against bacteria, fungi, viruses, and parasites. However, it poses significant health hazards including irritation to skin/eyes/respiratory tract and carcinogenicity upon chronic exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on formalin.